Amgen By Your Side Patient Assistance Program: Uplizna

The Assistance Fund for Neuromyelitis Optica Spectrum Disorder (NMOSD) offers financial support for FDA-approved treatments, including Uplizna, covering out-of-pocket costs, insurance premiums, and medical expenses. It is open to US and Puerto Rico residents with commercial insurance, Medicare, or Medicaid, and eligibility is based on financial need, requiring annual re-enrollment.

Eligibility

Eligible applicants must be residents of the US or Puerto Rico with a diagnosis of NMOSD and have commercial, Medicare, or Medicaid insurance. The program is needs-based and provides assistance for out-of-pocket costs, insurance premiums, and medical expenses for patients using FDA-approved treatments.